Intas Pharmaceuticals, Ltd. is a global leader in developing,
manufacturing, and marketing generics, biosimilars, and added-value medicines.
In 2024-25, it achieved USD 2.4 billion in sales, operating in over 85
countries worldwide About
two thirds of its revenue comes from international markets,
especially the EU and the US.
Intas has four GMP sites in India, two in the UK, on...